The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| SMLR | -20.09% | -63.98% | -18.47% | +243% |
| S&P | +18.54% | +92.9% | +14.04% | +269% |
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers’ patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.
The medical device company has made a peculiar bet on a popular cryptocurrency.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $8.22M | -43.2% |
| Gross Profit | $7.48M | -43.4% |
| Gross Margin | 91.01% | -0.3% |
| Market Cap | $432.01M | 77.7% |
| Market Cap / Employee | $5.47M | 0.0% |
| Employees | 79 | -14.1% |
| Net Income | $66.93M | 608381.8% |
| EBITDA | -$1.94M | -134.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $13.62M | 82.4% |
| Accounts Receivable | $2.83M | -62.1% |
| Inventory | 0.6 | 44.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00M | -100.0% |
| Short Term Debt | $0.02M | -73.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 12.20% | -7.5% |
| Return On Invested Capital | 31.33% | -19.5% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $0.45M | -91.0% |
| Operating Free Cash Flow | $0.51M | -89.6% |
| Metric | Q2 2024 | Q3 2024 | Q4 2024 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 16.92 | 11.49 | 10.99 | 15.96 | 51.83% |
| Price to Book | 1.96 | 4.50 | 1.50 | 2.30 | -24.75% |
| Price to Sales | 3.11 | 8.22 | 7.06 | 12.16 | 179.87% |
| Price to Tangible Book Value | 8.03 | 18.42 | 1.50 | 2.30 | -24.75% |
| Price to Free Cash Flow TTM | 10.12 | 18.99 | 20.80 | 42.89 | 162.00% |
| Enterprise Value to EBITDA | 32.70 | 122.94 | -274.01 | -262.54 | -671.55% |
| Free Cash Flow Yield | 9.9% | 5.3% | 4.8% | 2.3% | -61.83% |
| Return on Equity | 20.4% | 27.0% | -24.9% | 16.0% | -27.15% |
| Total Debt | $0.09M | $0.07M | $0.05M | $0.02M | -79.31% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
